Children's Hospital Colorado

REMODEL

May 12, 2022
Diagnosis
Type 2 diabetes
Age
18+
COMIRB number
21-2645

Overview

In this study, we are trying to assess if taking a medication called semaglutide versus a placebo can improve outcomes for patients with type 2 diabetes and kidney disease.

Study visits will be held at the Clinical and Translational Research Center (CTRC) at the University of Colorado Hospital Leprino Building.

Contact us

For questions or if you are interested in participating, please contact Maureen.pushea@childrenscolorado.org or 805-286-2524.